ATE424459T1 - Apo-3 ligand - Google Patents

Apo-3 ligand

Info

Publication number
ATE424459T1
ATE424459T1 AT98953378T AT98953378T ATE424459T1 AT E424459 T1 ATE424459 T1 AT E424459T1 AT 98953378 T AT98953378 T AT 98953378T AT 98953378 T AT98953378 T AT 98953378T AT E424459 T1 ATE424459 T1 AT E424459T1
Authority
AT
Austria
Prior art keywords
ligand
apo
lymphotoxin
homolog
antibodies
Prior art date
Application number
AT98953378T
Other languages
English (en)
Inventor
Avi Ashkenazi
Scot Marsters
Robert Pitti
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE424459T1 publication Critical patent/ATE424459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)
AT98953378T 1997-10-10 1998-10-09 Apo-3 ligand ATE424459T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6203797P 1997-10-10 1997-10-10
US6986297P 1997-12-17 1997-12-17

Publications (1)

Publication Number Publication Date
ATE424459T1 true ATE424459T1 (de) 2009-03-15

Family

ID=26741792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953378T ATE424459T1 (de) 1997-10-10 1998-10-09 Apo-3 ligand

Country Status (9)

Country Link
US (2) US20080171037A1 (de)
EP (2) EP1967587A1 (de)
JP (1) JP2001522584A (de)
AT (1) ATE424459T1 (de)
AU (1) AU749948B2 (de)
CA (1) CA2305713A1 (de)
DE (1) DE69840631D1 (de)
IL (1) IL135051A0 (de)
WO (1) WO1999019490A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0105044A3 (en) * 1999-01-15 2004-07-28 Biogen Inc Cambridge Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
JP4716578B2 (ja) 1999-04-12 2011-07-06 ジェネンテック， インコーポレイテッド 腫瘍壊死因子相同体及びそれをコードする核酸
US6994976B1 (en) * 1999-11-19 2006-02-07 Tittle Thomas V Tr3-specific binding agents and methods for their use
AU784504B2 (en) * 1999-11-19 2006-04-13 Thomas V. Tittle TR3-specific binding agents and methods for their use
US6727225B2 (en) 1999-12-20 2004-04-27 Immunex Corporation TWEAK receptor
JP5148795B2 (ja) * 1999-12-20 2013-02-20 イミュネックス・コーポレーション Ｔｗｅａｋ受容体
IL150755A0 (en) 2000-02-16 2003-02-12 Genentech Inc Uses of agonists and antagonists to modulate activity of tnf-related molecules
NZ522741A (en) 2000-05-08 2005-06-24 Biogen Idec Inc Method for promoting neovascularization using a TWEAK agonist and an angiogenic factor, such as fibroblast growth factor and VEGF
US7208151B2 (en) 2001-09-12 2007-04-24 Biogen Idec Ma Inc. Tweak receptor agonists as anti-angiogenic agents
MXPA04009683A (es) 2002-04-09 2005-01-11 Biogen Idec Inc Metodos para el tratamiento de condiciones relacionadas a tweak.
WO2005010045A1 (en) 2003-07-24 2005-02-03 Amgen Inc. Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor
DK2332408T3 (da) 2005-02-17 2013-12-02 Biogen Idec Inc Behandling af neurologiske sygdomme
CA2607697C (en) 2005-05-10 2015-01-06 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
CN102441163A (zh) 2005-05-27 2012-05-09 比奥根艾迪克Ma公司 结合tweak的抗体
WO2006138219A2 (en) 2005-06-13 2006-12-28 Biogen Idec Ma Inc. Methods of diagnosis / prognosis of inflammatory conditions
AU2006318539B2 (en) 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
US8093006B2 (en) 2009-04-02 2012-01-10 Hoffmann-La Roche Inc. Antibodies against human tweak and uses thereof
EP4320445A1 (de) 2021-04-08 2024-02-14 Joslin Diabetes Center, Inc. Verfahren zur diagnose und vorhersage von nierenabbau

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0206448B1 (de) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1987005330A1 (en) 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Method for enhancing glycoprotein stability
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
JPH04501201A (ja) 1987-12-21 1992-03-05 ジ・アップジョン・カンパニー 発芽植物種子類のアグロバクテリウム媒介形質転換
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
EP0586505A1 (de) 1991-05-14 1994-03-16 Repligen Corporation Heterokonjugat-antikörper zur behandlung von hiv-infektionen
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
JP3589665B2 (ja) 1992-10-23 2004-11-17 イミュネックス・コーポレーション 可溶性オリゴマー蛋白質の調製法
US6030945A (en) * 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
CA2249206A1 (en) * 1996-04-01 1997-10-09 Genentech, Inc. Apo-2li and apo-3 apoptosis polypeptides
US7129061B1 (en) * 1996-08-07 2006-10-31 Biogen Idec Ma Inc. Tumor necrosis factor related ligand
SI0956351T1 (sl) * 1996-08-07 2006-02-28 Biogen Idec Inc Ligand, sosroden faktorju tumorske nekroze
CA2280231A1 (en) * 1997-02-12 1998-08-13 Abbott Laboratories Member of the tnf family useful for treatment and diagnosis of disease

Also Published As

Publication number Publication date
EP1021542B1 (de) 2009-03-04
JP2001522584A (ja) 2001-11-20
US20080213837A1 (en) 2008-09-04
AU1077099A (en) 1999-05-03
DE69840631D1 (de) 2009-04-16
WO1999019490A1 (en) 1999-04-22
EP1967587A1 (de) 2008-09-10
US20080171037A1 (en) 2008-07-17
IL135051A0 (en) 2001-05-20
EP1021542A1 (de) 2000-07-26
AU749948B2 (en) 2002-07-04
WO1999019490A9 (en) 1999-06-24
CA2305713A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
DE69840631D1 (de) Apo-3 ligand
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
DK0981618T3 (da) Anti-Apo-2-antistof
DE69801321D1 (de) Slurrykohlenwasserstoffsyntheseverfahren mit mehrstufenkatalysatorwiederbelebung
DE69427932D1 (de) Katalysator zur katalytischen Reduktion von Stickstoffoxiden
DE69834649D1 (de) Tie ligand-homologuen
DE69009601D1 (de) Katalysator zur Reinigung von Abgas.
DE69804234D1 (de) Direkte polyoxyalkylierung von glyzerin mit doppel-metall-cyanid-katalyse
DE3587864D1 (de) Rekombinant-dns-moleküle.
DE59804828D1 (de) Multimetallcyanidkomplexe als katalysatoren
DE69010984D1 (de) Katalysator zur Reduktion von Stickoxyden.
DE69818240D1 (de) Neue katalysatoren
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
FI871124L (fi) Polypeptid, dna och dess anvaendning.
DE69840413D1 (de) Dna 19355 polypeptide, ein homolog des tumornekrosefaktors
DE60237777D1 (de) Etzungen und verfahren zur gezielten herunterregulierung von angiogenese und zur krebstherapie
DE59005310D1 (de) Mit flüssigem Brennstoff betriebenes Heizgerät.
FI862531A7 (fi) Kasvainnekroositekijä.
DE69205169D1 (de) Wirbelmischerantrieb.
FI860677L (fi) Rinovirusstammens hrv2 polypeptid och de haerfoer kodande dna-molekylerna.
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
DK0708831T3 (da) Celletæthedsforstærkende proteintyrosinphosphataser
DE3860683D1 (de) Verwendung von fluormethylphenolen als loesungsmittel fuer lc-polymere, und neue fluormethylphenole.
DE69812650D1 (de) Rückgewinnung von molybdan katalysator
DE68900369D1 (de) Kohlenoxid-calzinierung von methanolspaltkatalysatoren.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties